Bhaskar Chaudhuri, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 20,000 shares at $35.97 ($710K) on 2021-02-22, disclosed to the SEC on 2021-02-24.
Open-market sale of $710k ARQT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.34 | 7,211 | $255K | 35.9% |
| 2 | $35.34 | 7,211 | $255K | 35.9% |
| 3 | $35.97 | 2,789 | $100K | 14.1% |
| 4 | $35.97 | 2,789 | $100K | 14.1% |
| Total | $35.52 avg | 20,000 | $710K | 100% |
| Filing → |
| ARQT | SELL | 2021-06-03 | $275K | — | Filing → |
| ARQT | SELL | 2021-05-19 | $525K | — | Filing → |
| ARQT | SELL | 2021-03-24 | $622K | — | Filing → |